Drug Treatment for Hypertensive Patients in Special Situations: Diabetes and Hypertension

References

• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329: 977–86
   PubMed Web of Science ®Google Scholar
• UKPDS 33. An intensive blood glucose control policy with sulphonylureas or insulin reduces the risk of diabetic complications in patients with Type 2 diabetes. Lancet 1998; 352: 837–853
   PubMed Web of Science ®Google Scholar
• UKPDS 34. Effect of an intensive blood glucose control policy with metformin on complications in Type 2 diabetic patients. Lancet 1998; 352: 854–865
   PubMed Web of Science ®Google Scholar
• Gaster B., Hirsch I. B. The effects of improved glycemic control on complications in type 2 diabetes. Arch Intern Med 1998; 158: 134–140
   PubMed Web of Science ®Google Scholar
• Wang P. H., Lau J., Chalmers C. T. Meta-analysis of effects of intensive blood-glocuse control on late complications of type 1 diabetes. Lancet 1993; 341: 1306–1309
   PubMed Web of Science ®Google Scholar
• Parving H-H. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment (review). Diabetologia 1998; 41: 745–759
   PubMed Web of Science ®Google Scholar
• Turner R., Holman R., Stratton I., Cull C., Frighi V., Manley S., et al. for United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: United Kingdom prospective diabetes study 38. BMJ 1998; 317: 703–713
   PubMed Web of Science ®Google Scholar
• Cooper M., McNally P. Antihypertensive treatment in NIDDM, with special reference to abnormal albuminuria, 419–434. The kidney and hypertension in diabetes mellitus4th ed., C. E. Mogensen. Kluwer Academic Publ. 1998
   Google Scholar
• Ravid M., Brosh D., Levi Z., Bar-Dayan Y., Ravid D., Rachmani R. Use of enalapril to attenuate decline in renal function in normotensive patients with type 2 diabetes mellitus. A randomized controlled trial. Ann. Intern. Med 1998; 128: 982–988
   PubMed Web of Science ®Google Scholar
• Knowler W. C., Bennett P. H., Ballintine E. J. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians N Engl J Med 1980; 302(12)645–650, 419–434
   Google Scholar
• Curb J. D., Pressel S. L., Cutler J. A., Savage P. J., Applegate W. B., Black H., et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276(23)1886–92
   PubMed Web of Science ®Google Scholar
• Holman R., Turner R., Stratton I., Cull C., Frighi V., Manley S., et al. for United Kingdom Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: United Kingdom prospective diabetes study 39. BMJ 1998; 317: 713–720
   PubMed Web of Science ®Google Scholar
• Tatti P., Pahor M., Byington R. P., Di Mauro P., Guarisco R. G., Strollo G., Strollo F. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trials (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998; 21: 597–603
   PubMed Web of Science ®Google Scholar
• Tuomilehto J., Rastenyte D., Thisj L., Staessen J. Reduction of mortality and cardiovascular events in older diabetic patients with isolated systolic hypertension in Europe treated with nitrendipine-based antihypertensive therapy (Syst-Eur-Trial). Diabetes 1998; 47: A54, (abstract).
   Google Scholar
• Hansson L., Zanchetti A., Carruthers S. G., Dahlof B., Elmfeldt D., Julius S., et al, HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. The Lancet 1998; 351: 1755–62
   PubMed Web of Science ®Google Scholar
• Estacio R. O., Jeffers B. W., Hiatt R. A., Biggerstaff S. L., Gifford N., Schrier R. W. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 645–652
   PubMed Web of Science ®Google Scholar
• Turner R. C., Millns H., Neil H. A., Stratton I. M., Manley S. E., Matthews D. R., et al, United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). BMJ 1998; 316: 823–8
   PubMed Web of Science ®Google Scholar
• Mogensen C. E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 1982; 285: 685–688
   PubMed Web of Science ®Google Scholar
• Lewis E., Hunsicker L., Bain R., Rhode R. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456–1462
   PubMed Web of Science ®Google Scholar
• The EUCLID study group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787–92
   PubMed Web of Science ®Google Scholar
• Mogensen C. E. How to protect the kidney in diabetic patients: with special reference to IDDM. Diabetes 1997; 46(suppl 2)S104–11
   PubMed Web of Science ®Google Scholar
• Ravid M., Lang R., Rachmani R., Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med 1996; 156: 286–289
   PubMed Web of Science ®Google Scholar
• Nielsen F. S., Rossing P., Gall M-A, Skott P., Smidt UM, Parving H-H. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects. With diabetic nephropathy. Diabetes 1997; 46: 1182–8
   PubMed Web of Science ®Google Scholar
• Hansson L., Lindholm L. H., Niskanen L., Lanke J., Hedner T., Niklason A, et al. Principal results of the Captopril Prevention Project (CAPPP). Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. Lancet, (in press)
   Web of Science ®Google Scholar
• Crepaldi G., Carta Q., Deferrari G., Mangili R., Navalesi R., Santeusanio F., Spalluto A., Vanasia A., Nosadini R. and The Italian Microalbuminuria Study Group in EDDM. Effects of Lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. Diabetes Care 1998; 21(1)104–111
   PubMed Web of Science ®Google Scholar
• Mogensen CE. Kluwer Academic Publishers, Boston, Dordrecth, London 1998
   Google Scholar